Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Intergroup comparison for dialysis patients according to CAC level at baseline ( n= 65)

From: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

   CAC <100 CAC >100 (65%)
N [n, (%)] 23 (35%) 42 (65%)
Gender (male) [n, (%)] 10 (45%) 21 (50%)
Age [yrs] 51 ± 16 64 ± 12
Time since first dialysis [mo]   87 ± 88 64 ± 68
BMI [kg/m2] 26 ± 7 25 ± 5
CAC Agatston 28 ± 35 1014 ± 907  
AVC Agatson 14 ± 35 88 ± 266  
ucMGP [nmol/L] 2199 ± 714 2423 ± 725
Fetuin-A [g/L] 0.47 ± 0.12 0.45 ± 0.08
OPG [pmol/L] 4.13 ± 2.62 5.95 ± 2.53
Sclerostin [ng/mL] 1.52 ± 0.71 1.54 ± 0.86
CRP [mg/L] 4.19 ± 6.35 8.05 ± 6.67
iPTH [pg/mL] 119 ± 139 282 ± 396
BAP [U/L] 29 ± 22 33 ± 28
AP [U/L] 82 ± 46 89 ± 72
Total Ca2+ [mmol/L] 2.25 ±0.27 2.39 ± 0.29
Phosphorus [mmol/L] 1.77 ± 0.53 1.83 ± 0.50
Albumin [g/L] 39 ± 8 39 ± 4
Haemoglobin [g/L] 109 ± 14 109 ± 27
S-Creatinine [mg/dL] 9.7 ± 3.2 9.1 ± 2.6
S-Urea [mmol/L] 82 ± 60 62 ± 61